Form 4 for MGX Metagenomi Therapeutics, Inc.
Accepted 2025-12-01 00:00:00 ET · period of report 2025-09-05 · accession 0001193125-25-304221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-09-05 | MGX | Thomas Brian C. | Dir | S - Sale | $1.81 | -2,701 | 2.51M | -0.1% | -$4,889 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 2,701 | $1.81 | 2,514,790 | D | — | — |